Answer
Co-administration with rifampicin decreases eravacycline exposure by approximately 32% and increases clearance by approximately 54%; the eravacycline dose should therefore be increased by approximately 50% to 1.5 mg/kg intravenously every 12 hours.
Sources for this answer
- Xerava 100 mg powder for concentrate for solution for infusionPAION UK Ltd · emc · SmPC §4.5 Interaction with other medicinal products · Version 3Document updated
Sources checked